UnitedHealth's Improving Medical Costs Signal Progress in Turnaround as 2027 Outlook Strengthens

Lower Medical Costs and Stronger Margins Support UnitedHealth's Recovery

UnitedHealth Group (UNH) reported stronger-than-expected third-quarter earnings on October 13, 2026, and raised its full-year profit outlook as improving medical cost trends and operational restructuring supported profitability. The results marked further progress in the healthcare giant's turnaround following a difficult 2025.

Adjusted earnings reached $4.69 per share, comfortably exceeding Wall Street expectations, while revenue totaled approximately $112.7 billion. Despite the earnings beat, shares finished Tuesday's session slightly lower after an initial rally, suggesting investors were looking beyond quarterly results toward the sustainability of the company's recovery.

Key Points

• Medical costs show improvement: UnitedHealth's medical care ratio declined to 88.4%, beating expectations and supporting stronger operating margins.
• Earnings guidance moves higher: The company raised its 2026 adjusted earnings outlook to at least $20.50 per share, while management pointed to renewed earnings growth potential in 2027.
• Turnaround challenges remain: Medicare Advantage membership has declined significantly, while specialty drug costs, commercial insurance pressures and regulatory uncertainty continue to affect the business.

UnitedHealth Earnings Show Improving Profitability Despite Flat Revenue

UnitedHealth's third-quarter results reflected improving operating performance even as revenue growth remained limited.

The company reported adjusted earnings of $4.69 per share, above analyst expectations of approximately $4.14. Revenue reached $112.7 billion, slightly exceeding forecasts but remaining essentially unchanged from the previous year.

Net income totaled approximately $4.1 billion.

The earnings improvement was supported by stronger margins, disciplined spending and changes to the company's insurance portfolio.

Operating margin increased to 5.8%, compared with 3.8% a year earlier.

Medical Cost Ratio Becomes a Key Indicator

One of the most important developments was the improvement in UnitedHealth's medical care ratio.

The metric measures the percentage of insurance premium revenue spent on medical claims. A lower ratio generally indicates that an insurer is retaining more premium revenue after covering healthcare expenses.

UnitedHealth reported a medical care ratio of 88.4%, down from 89.9% a year earlier and below Wall Street expectations.

The improvement was partly supported by approximately $610 million in favorable developments related to prior periods, meaning previously estimated medical expenses ultimately proved lower than anticipated.

Even excluding that benefit, the ratio performed better than analysts expected, according to Mizuho Securities.

Management also reported moderation in medical costs across much of its Medicare business, although specialty pharmaceuticals remain an important source of pressure.

Chief Financial Officer Wayne DeVeydt cautioned that medical expenses are still elevated compared with historical levels.

The results therefore suggest progress in cost management without establishing that the broader healthcare spending environment has returned to normal.

Higher Guidance Establishes a Stronger Earnings Base

UnitedHealth raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, compared with its previous range of $19.50 to $20.

The revision reflects management's improving confidence in operating performance and the company's ongoing restructuring efforts.

Looking ahead, DeVeydt indicated that the lower end of UnitedHealth's long-term earnings growth target of 13% to 16% represents a reasonable starting point for 2027.

Management also suggested that current analyst expectations for next year may not fully reflect the company's recovery potential.

UnitedHealth plans to provide a more comprehensive 2027 outlook before year-end.

Why Is UnitedHealth Shrinking Its Medicare Membership?

UnitedHealth's turnaround has involved a deliberate reduction in certain insurance businesses as management works to restore profitability.

Following a difficult 2025 marked by unexpectedly high medical expenses, the company began exiting less profitable contracts, adjusting benefits and withdrawing from selected markets.

These actions have improved the financial performance of parts of the insurance portfolio but reduced membership.

Through the third quarter, UnitedHealth was serving approximately 935,000 fewer Medicare Advantage members than at the end of 2025.

Overall UnitedHealthcare membership declined to 48.3 million from 50.1 million a year earlier.

The company also lost approximately 165,000 commercial members during the third quarter.

Medicare Advantage Restructuring Supports Margins

Medicare Advantage is a major component of UnitedHealth's insurance business, providing privately administered health coverage to eligible Medicare beneficiaries.

The company has been refining its portfolio to focus on plans and markets where it believes it can achieve more sustainable profitability.

Management expects Medicare margins to finish 2026 near the upper end of its targeted range of 2% to 4%.

The strategy has involved accepting lower membership in exchange for improved pricing discipline and reduced exposure to unprofitable contracts.

UnitedHealth is also identifying growth opportunities in specialized Medicare plans serving patients with chronic conditions and individuals eligible for both Medicare and Medicaid.

With Medicare's annual enrollment period beginning in October, management indicated that renewed membership growth could become possible in 2027.

However, the company continues to face elevated healthcare utilization and spending pressures.

Commercial Insurance and Medicaid Remain Challenging

Outside Medicare, UnitedHealth continues to manage higher-than-expected medical costs in commercial insurance.

Specialty pharmaceuticals, rising clinician expenses and disputes under the No Surprises Act have contributed to the pressure.

Management said commercial medical cost trends remain elevated but are showing signs of stabilization rather than further acceleration.

Medicaid profitability also remains under pressure because of differences between healthcare costs and reimbursement rates set by states.

UnitedHealth expects 2026 to represent a low point for Medicaid margins, with management targeting a recovery toward its longer-term objectives by 2028.

These challenges underscore why improving profitability remains central to the company's turnaround.

Optum Recovery and AI Investments Support Operational Improvements

UnitedHealth's Optum businesses are another important component of the recovery.

Optum provides healthcare services, pharmacy benefits, technology and care delivery capabilities alongside UnitedHealthcare's insurance operations.

Optum Health, which operates physician practices and other care services, reported substantial improvement in profitability during the third quarter.

Operating earnings reached approximately $735 million, compared with $41 million a year earlier.

Management attributed the improvement to tighter medical cost management, operational discipline and changes to the business.

The company continues to focus on accountable care, home health, hospice and other services intended to improve patient outcomes while managing healthcare spending.

Value-Based Care Helps Reduce Hospital Utilization

UnitedHealth has emphasized value-based care as part of its operating strategy.

Under this model, healthcare providers are compensated partly based on patient outcomes and quality of care rather than solely on the number of services delivered.

Management reported that acute hospital admissions declined 15% through the third quarter compared with a year earlier, while home health admissions increased.

The company also highlighted fewer hospitalizations and readmissions among certain Medicare Advantage patients participating in value-based care arrangements.

These developments support UnitedHealth's efforts to manage medical spending through preventive care and more coordinated treatment.

AI Tools Target Administrative Efficiency

UnitedHealth is also expanding the use of artificial intelligence and automation across its insurance and healthcare operations.

Management highlighted AI-enabled chart summarization tools that have been deployed to more than 40% of employed clinicians.

According to the company, these tools have reduced chart review time by approximately one-third, allowing clinicians to spend less time on administrative tasks.

UnitedHealth also reported a 26% reduction in appeal processing times and initiatives intended to reduce prior authorization requirements.

Within Optum Insight, the company's Integrity One platform has expanded from two implemented clients at the end of 2025 to 15, with additional implementations underway.

Management expects technology modernization and workflow automation to support productivity improvements across its businesses.

However, the company is continuing to invest in these capabilities, making execution and cost management important factors in their financial contribution.

What It Means for Investors

UnitedHealth's third-quarter earnings provide further evidence that its operational turnaround is progressing.

Improving medical cost ratios, stronger operating margins and the recovery in Optum Health profitability indicate that restructuring efforts are beginning to affect financial performance.

The higher earnings outlook also establishes a stronger starting point for management's expectations heading into 2027.

However, the recovery remains incomplete.

UnitedHealth has reduced Medicare Advantage membership substantially while exiting less profitable business, creating a trade-off between near-term profitability and the size of its insurance portfolio.

Medical costs also remain elevated, particularly in commercial insurance and specialty pharmaceuticals.

The company faces additional uncertainty from Medicaid reimbursement, regulatory changes and healthcare policy developments.

The stock's relatively muted reaction to the earnings announcement suggests that investors had already anticipated some improvement.

Analysts have nevertheless responded positively to the results.

Morgan Stanley (MS) raised its price target to $529 from $468 while maintaining an Overweight rating, and Mizuho reiterated its favorable assessment of the company's improving profitability.

Those analyst views reflect expectations rather than guaranteed outcomes.

The most important developments to monitor are whether medical cost improvements continue, how Medicare membership evolves during the upcoming enrollment cycle, and whether Optum can sustain its recovery.

UnitedHealth's forthcoming 2027 outlook should also provide additional clarity on management's earnings expectations and the financial impact of ongoing investments.

Conclusion

UnitedHealth's third-quarter results showed meaningful progress in restoring profitability after a difficult period for the healthcare insurer.

Adjusted earnings exceeded expectations, medical costs moderated and operating margins improved, allowing management to raise its full-year earnings outlook.

The recovery in Optum Health and continued investments in value-based care and AI-supported operations provide additional evidence of the company's restructuring efforts.

Nevertheless, shrinking Medicare membership, elevated commercial medical costs and regulatory uncertainty remain important challenges.

The next phase of UnitedHealth's turnaround will depend on whether the company can sustain its margin improvements while returning to more consistent membership and earnings growth.

FAQs

Why did UnitedHealth raise its 2026 earnings guidance?

UnitedHealth raised its full-year adjusted earnings outlook to at least $20.50 per share after stronger-than-expected third-quarter results. Improving medical cost management, higher operating margins and better performance at Optum contributed to the revision.

What is UnitedHealth's medical care ratio, and why does it matter?

The medical care ratio measures the percentage of insurance premium revenue spent on medical claims. UnitedHealth's ratio declined to 88.4% in the third quarter, indicating improved cost management compared with the previous year.

Why has UnitedHealth lost Medicare Advantage members?

UnitedHealth has reduced its Medicare Advantage membership as part of a restructuring effort focused on exiting less profitable contracts, adjusting benefits and improving margins. Membership declined by approximately 935,000 from the end of 2025 through the third quarter of 2026.

How is Optum contributing to UnitedHealth's turnaround?

Optum Health reported a substantial improvement in operating earnings, supported by medical cost management and operational changes. UnitedHealth is also expanding value-based care and AI-supported administrative tools across its healthcare businesses.

What are the main risks facing UnitedHealth in 2027?

UnitedHealth continues to face elevated commercial medical costs, specialty pharmaceutical expenses, Medicaid reimbursement challenges and regulatory uncertainty. Investors are also monitoring whether Medicare membership and Optum profitability can improve sustainably.

This article was created with AI assistance and reviewed by an editor. For details, please refer to our Terms of Use.

Go Beyond the Market Brief with Market Edge

Follow SharperTrades’ complete approach to trading and investing, combining active trade opportunities through Block Orders, long-term research through Stock Investor, and structured market education through the Swing Trading Masterclass. Try Market Edge for $19 your first month →

Explore Research with Stock Investor

Stock Investor is SharperTrades’ platform for long-term investing research and portfolio management. Members receive research reports, portfolio updates, conviction tracking, and in-depth analysis designed to support disciplined investment decisions.

Explore Active Trading & Income Strategies

Block Orders tracks institutional activity and highlights active trade setups and price behavior across long and short opportunities.

For options-focused traders, Essential Option Income provides a structured approach to options income strategies, while Pro Option Trader offers a broader range of options strategies and trade opportunities.

Think More Clearly with SteadyCapital

SteadyCapital is SharperTrades’ decision-support system for long-term investors, built around the SteadyCapital Method™. Review investment ideas, challenge assumptions, evaluate valuation and risk, compare companies, and think through important buy, hold, add, trim, or sell decisions before you act.

Risk Disclosure

All content is provided for educational purposes only and does not constitute investment advice. Trading involves risk, and past performance is not indicative of future results. Please review our full Risk Disclosure for additional information.